NEWS
FDA Will Regulate Tobacco Under New Law
Calling it a bill that "will save American lives," President Obama has signed into law the Family Smoking Prevention and Tobacco Control Act, which grants the Food and Drug Administration (FDA) the authority to regulate tobacco products. Under the law, the FDA now has sweeping new authorities related to the manufacture, marketing, and sale of tobacco products—authorities covered by a more expansive public health standard than has traditionally been granted to the agency. Read more > >
For Children with Leukemia, Radiation May Be Unnecessary
Study finds that cranial radiation can be omitted without compromising survivalSurvivors of Hodgkin Lymphoma May Face Increased Risk of Stroke
The risk stems from radiation therapy and remains elevated for yearsAnother Genetic Change Linked to Neuroblastoma: Missing DNA
Loss of gene on chromosome 1 may be a risk factor for the childhood cancerImmune Cells with Stem Cell-like Properties Destroy Tumors in Mice
CD8+ memory stem cells with anti-tumor activity show promise
COMMENTARY
Director's Update: Putting Some Perspective on Research and Risk
For as long as there has been a National Cancer Institute, its leaders have attempted to strike a delicate balance between the potentially huge payoffs of risk-taking science and the benefits of more measured progress that comes from incremental research. It is, I believe, a healthy tension that should always be part of discovery--perhaps most importantly when it involves our work on a disease such as cancer. The work we do in our laboratories, we always hope, can eventually be used to help our patients. To me, that puts each experiment I plan in my lab in a different light. Read more > >
Guest Commentary by Dr. Jeanette Vega: Chile and the United States—Forming a Proud Partnership
The Republic of Chile's Undersecretary of Public Health shares her thoughts on the collaborative efforts between our two countries in a number of important research areas, including basic and clinical cancer research, bioinformatics, and training and resource sharing. Read more > >
IN DEPTH
Special Report: MicroRNAs Show Promise for Detecting, Treating Cancer
The tiny nucleotide chains are poised to enter the clinicProfiles in Cancer Research: Dr. Bryce Reeve
As a program director in NCI's Outcomes Research Branch, Dr. Reeve is recognized as a leading expert in patient-reported outcomesFeatured Clinical Trial: Testing Trabectedin in Pediatric Patients
What is the safest maximum dose of trabectedin for children with advanced cancer?
UPDATES
Notes
- Dr. Diane Meier Participates in White House Health Reform Stakeholder Discussion
- NCI Scientists Featured in Journal of Minority Medical Students
- caBIG Annual Meeting Slated for July
- BSA Meeting Held
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

